News
Complete Two-Year Data Confirms That Medtronic's Evolut TAVR System Is Non-Inferior to Open Heart Surgery in Low Risk Patients
Confirming the preliminary data that was published in The New England Journal of Medicine, the complete data from over 1,400 patients enrolled in the Evolut Low Risk Trial was presented at this year's EuroPCR meeting by John K Forrest, MD, FACC, FSCAI.
Source: Angioplasty.Org